Literature DB >> 3956049

Nomogram for drug dosage adjustment in patients with renal failure.

T D Bjornsson.   

Abstract

A nomogram is presented for the rapid determination of the dosage adjustment factor for drugs eliminated in part by the kidneys in patients with reduced renal function. This nomogram method is based on knowledge of the fraction of a dose of the drug of interest eliminated by the kidneys in subjects with normal renal function and an estimation of the renal function of the patient in question. It assumes that there is no reduction in the liver metabolism of the drug in patients with reduced renal function. The dosage adjustment factor thus derived can be used to change the dosage regimen of the drug in patients with reduced renal function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956049     DOI: 10.2165/00003088-198611020-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  14 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  "Handbook of clinical drug data".

Authors:  J E Knoben; P O Anderson
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

Review 3.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

4.  Rapid evaluation of creatinine clearance.

Authors:  J Kampmann; K Siersbaek-Nielsen; M Kristensen; J M Hansen
Journal:  Acta Med Scand       Date:  1974-12

Review 5.  Hepatic first-pass metabolism in liver disease.

Authors:  T F Blaschke; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

6.  Estimation of kinetic parameters from a two-point determination of the drug cumulation factor.

Authors:  T D Bjornsson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

Review 7.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Nomogram for estimating creatinine clearance.

Authors:  T D Bjornsson; D M Cocchetto; F X McGowan; C P Verghese; F Sedor
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

9.  Prediction of creatinine clearance from serum creatinine concentration based on lean body mass.

Authors:  T Hallynck; H H Soep; J Thomis; J Boelaert; R Daneels; J P Fillastre; F De Rosa; E Rubinstein; M Hatala; J Spousta; L Dettli
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

Review 10.  Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics.

Authors:  W M Bennett; R S Muther; R A Parker; P Feig; G Morrison; T A Golper; I Singer
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

View more
  5 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 3.  Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations.

Authors:  T D Bjornsson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

Review 4.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 5.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.